We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1151
DELISTED
Verve Therapeutics
VERV
| $18.1M | 0.01% |
1,611,913
+287,244
| +22% | +$1.64M |
|
1152
Artisan Partners
APAM
$2.79B
| $18.1M | 0.01% |
408,297
-43,645
| -10% | -$1.74M |
|
1153
CorMedix
CRMD
$617M
| $18.1M | 0.01% |
1,468,721
+1,194,040
| +435% | +$13.2M |
|
1154
Aaon
AAON
$8.41B
| $18.1M | 0.01% |
245,053
-20,644
| -8% | -$1.81M |
|
1155
LegalZoom.com
LZ
$1.23B
| $18.1M | 0.01% |
2,026,001
-132,568
| -6% | -$1.11M |
|
1156
Clear Secure
YOU
$5.26B
| $17.9M | 0.01% |
645,766
-545,374
| -46% | -$13.9M |
|
1157
Dick's Sporting Goods
DKS
$18.4B
| $17.9M | ﹤0.01% |
90,498
-36,228
| -29% | -$6.71M |
|
1158
Worthington Enterprises
WOR
$2.76B
| $17.9M | ﹤0.01% |
280,990
+199,499
| +245% | +$11.1M |
|
1159
Celestica
CLS
$35.1B
| $17.9M | ﹤0.01% |
114,659
+32,968
| +40% | +$3.5M |
|
1160
Lantheus
LNTH
$6.82B
| $17.9M | ﹤0.01% |
218,197
-354,970
| -62% | -$31.2M |
|
|
DAY
1161
DELISTED
Dayforce
DAY
| $17.9M | ﹤0.01% |
322,431
-164,729
| -34% | -$9.41M |
|
1162
BridgeBio Pharma
BBIO
$16.5B
| $17.8M | ﹤0.01% |
411,907
-21,205
| -5% | -$771K |
|
1163
Celsius Holdings
CELH
$6.93B
| $17.8M | ﹤0.01% |
382,812
-100,703
| -21% | -$3.88M |
|
|
FYBR
1164
DELISTED
Frontier Communications
FYBR
| $17.7M | ﹤0.01% |
486,356
-180,348
| -27% | -$6.54M |
|
1165
Travere Therapeutics
TVTX
$5.33B
| $17.7M | ﹤0.01% |
1,194,335
-9,309
| -0.8% | -$154K |
|
1166
AST SpaceMobile
ASTS
$16.8B
| $17.7M | ﹤0.01% |
377,782
-28,267
| -7% | -$818K |
|
1167
Scholar Rock
SRRK
$5.71B
| $17.6M | ﹤0.01% |
496,553
+99,211
| +25% | +$3.11M |
|
1168
Darling Ingredients
DAR
$9.93B
| $17.6M | ﹤0.01% |
463,199
+93,622
| +25% | +$3.08M |
|
1169
Diamondrock Hospitality Co
DRH
$2.63B
| $17.5M | ﹤0.01% |
2,290,169
-75,314
| -3% | -$562K |
|
1170
Dorman Products
DORM
$4.01B
| $17.5M | ﹤0.01% |
142,899
-72,601
| -34% | -$8.83M |
|
|
OPLN
1171
Openlane
OPLN
$4.17B
| $17.5M | ﹤0.01% |
716,322
-47,440
| -6% | -$1M |
|
|
GAP
1172
The Gap Inc
GAP
$6.84B
| $17.5M | ﹤0.01% |
802,514
-42,955
| -5% | -$960K |
|
|
TWFG
1173
TWFG Inc
TWFG
$342M
| $17.5M | ﹤0.01% |
499,772
-1,719
| -0.3% | -$57.3K |
|
1174
Willdan Group
WLDN
$1.1B
| $17.5M | ﹤0.01% |
279,644
+26,380
| +10% | +$1.26M |
|
1175
Silicon Laboratories
SLAB
$7.15B
| $17.4M | ﹤0.01% |
118,209
-169,057
| -59% | -$20M |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.